MedTrace Logo

Aurora Test for ART Donor Patients (AURORA-Donor)

NCT06280677 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2025-08-11

No results posted yet for this study

Summary

This is a randomized observational study. The main aim is to determine potential oocyte competence predictive mRNA expression profiles in the cumulus cells isolated form individual oocytes. In 2 patient cohorts: 1)GnRH Antagonist \& hr-FSH with GnRH Agonist trigger, 2) Progesterone \& hr-FSH with GnRH Agonist trigger.

Conditions

Interventions

OTHER

AURORA-Donor

Explorative study of cumulus cells gene expression in relation to the oocyte competence for good quality blastocyst formation and predictive for clinical pregnancy.

Sponsors & Collaborators

  • Fertilab

    collaborator UNKNOWN

  • Ferring Pharmaceuticals

    collaborator INDUSTRY

  • Fertiga, Belgium

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-16
Primary Completion
2026-04-30
Completion
2026-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06280677 on ClinicalTrials.gov